Clinical Trial Protocol Registry

Trial information

A Study of NT-Pro Brain Natriuretic Peptide (NT-proBNP) in Patients Presenting With Acute Dyspnea.

Status:
Completed
Protocol number:
CAN0010
Company division:
Diagnostics
Official Scientific Title:
The 'improved management of patients with congestive heart failure in Canada (IMPROVE-CHF CANADA)' study.
Brief summary:
This study will evaluate the use of plasma NT-proBNP measurements to improve the diagnostic accuracy of congestive heart failure (CHF) and the prediction of clinical outcomes in patients who present to emergency departments with acute dyspnea. Patients will be randomized to a conventional care group, or to conventional care plus measurement of plasma NT-proBNP.
Study type:
Interventional; Randomized; Double Blind; Parallel study
Conditions:
  • Congestive Heart Failure
Intervention type:
Diagnostic Test
Intervention name:
ELECSYS®proBNP
Inclusion criteria:
  • adult patients, >=18 years of age;
  • presenting to emergency department with shortness of breath, of suspected cardiac etiology.
Exclusion criteria:
  • dyspnea clearly not due to CHF;
  • acute myocardial infarction;
  • advanced renal failure.
Gender:
Males or Females
Age limits:
Min: 18Years
Accepts healthy volunteers:
No
Anticipated start date:
December, 2004
Trial registration date:
23.11.2006
Date last updated:
08.12.2006
This trial was conducted at the following locations:
Canada
  • Calgary, AB
  • Vancouver, BC
  • Halifax, NS
  • Hamilton, ON
  • Toronto, ON
  • Montreal, QC
  • Quebec, QC

Link to trial result

For more information on a specific Roche trials in your country location, please contact your local Roche affiliate nearest you.

  • Go on the URL link- http://www.roche.com and click on the Roche Worldwide tab on the top of the page to locate the country nearest you for contact information.

Treatment decisions and/or suitability for a specific trial are decisions only your healthcare provider can make. If you are patient interested in any of the global studies, please have your healthcare provider contact us and they will be provided with the relevant clinical trial information.

For US or global trials with US sites only, please contact the Trial Information Support Line (TISL)